Global Carcinoembryonic Antigen (CEA) Market Research Report 2023

Report ID: 1991965 | Published Date: Sep 2024 | No. of Page: 66 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 CD66a
        1.2.3 CD66b
        1.2.4 CD66c
        1.2.5 CD66d
        1.2.6 CD66e
        1.2.7 CD66f
    1.3 Market by Application
        1.3.1 Global Carcinoembryonic Antigen (CEA) Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Colorectal Cancer
        1.3.3 Pancreatic Cancer
        1.3.4 Ovarian Cancer
        1.3.5 Breast Cancer
        1.3.6 Thyroid Cancer
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Carcinoembryonic Antigen (CEA) Market Perspective (2018-2029)
    2.2 Carcinoembryonic Antigen (CEA) Growth Trends by Region
        2.2.1 Global Carcinoembryonic Antigen (CEA) Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Carcinoembryonic Antigen (CEA) Historic Market Size by Region (2018-2023)
        2.2.3 Carcinoembryonic Antigen (CEA) Forecasted Market Size by Region (2024-2029)
    2.3 Carcinoembryonic Antigen (CEA) Market Dynamics
        2.3.1 Carcinoembryonic Antigen (CEA) Industry Trends
        2.3.2 Carcinoembryonic Antigen (CEA) Market Drivers
        2.3.3 Carcinoembryonic Antigen (CEA) Market Challenges
        2.3.4 Carcinoembryonic Antigen (CEA) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue
        3.1.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue (2018-2023)
        3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2018-2023)
    3.2 Global Carcinoembryonic Antigen (CEA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Carcinoembryonic Antigen (CEA) Revenue
    3.4 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio
        3.4.1 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen (CEA) Revenue in 2022
    3.5 Carcinoembryonic Antigen (CEA) Key Players Head office and Area Served
    3.6 Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
    3.7 Date of Enter into Carcinoembryonic Antigen (CEA) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Carcinoembryonic Antigen (CEA) Breakdown Data by Type
    4.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2018-2023)
    4.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2024-2029)
5 Carcinoembryonic Antigen (CEA) Breakdown Data by Application
    5.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Application (2018-2023)
    5.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
    6.2 North America Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2023)
    6.4 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
    7.2 Europe Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2023)
    7.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
    8.2 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2018-2023)
    8.4 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
    9.2 Latin America Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2023)
    9.4 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
    10.2 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2023)
    10.4 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Roche Diagnostics
        11.1.1 Roche Diagnostics Company Detail
        11.1.2 Roche Diagnostics Business Overview
        11.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Introduction
        11.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2018-2023)
        11.1.5 Roche Diagnostics Recent Development
    11.2 Abbott Diagnostics
        11.2.1 Abbott Diagnostics Company Detail
        11.2.2 Abbott Diagnostics Business Overview
        11.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Introduction
        11.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2018-2023)
        11.2.5 Abbott Diagnostics Recent Development
    11.3 Quest Diagnostics
        11.3.1 Quest Diagnostics Company Detail
        11.3.2 Quest Diagnostics Business Overview
        11.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Introduction
        11.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2018-2023)
        11.3.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of CD66a
    Table 3. Key Players of CD66b
    Table 4. Key Players of CD66c
    Table 5. Key Players of CD66d
    Table 6. Key Players of CD66e
    Table 7. Key Players of CD66f
    Table 8. Global Carcinoembryonic Antigen (CEA) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Carcinoembryonic Antigen (CEA) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Carcinoembryonic Antigen (CEA) Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Carcinoembryonic Antigen (CEA) Market Share by Region (2018-2023)
    Table 12. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Carcinoembryonic Antigen (CEA) Market Share by Region (2024-2029)
    Table 14. Carcinoembryonic Antigen (CEA) Market Trends
    Table 15. Carcinoembryonic Antigen (CEA) Market Drivers
    Table 16. Carcinoembryonic Antigen (CEA) Market Challenges
    Table 17. Carcinoembryonic Antigen (CEA) Market Restraints
    Table 18. Global Carcinoembryonic Antigen (CEA) Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Carcinoembryonic Antigen (CEA) Market Share by Players (2018-2023)
    Table 20. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2022)
    Table 21. Ranking of Global Top Carcinoembryonic Antigen (CEA) Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Carcinoembryonic Antigen (CEA) Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
    Table 25. Date of Enter into Carcinoembryonic Antigen (CEA) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Carcinoembryonic Antigen (CEA) Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2018-2023)
    Table 29. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2024-2029)
    Table 31. Global Carcinoembryonic Antigen (CEA) Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Application (2018-2023)
    Table 33. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Application (2024-2029)
    Table 35. North America Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Carcinoembryonic Antigen (CEA) Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Roche Diagnostics Company Detail
    Table 51. Roche Diagnostics Business Overview
    Table 52. Roche Diagnostics Carcinoembryonic Antigen (CEA) Product
    Table 53. Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2018-2023) & (US$ Million)
    Table 54. Roche Diagnostics Recent Development
    Table 55. Abbott Diagnostics Company Detail
    Table 56. Abbott Diagnostics Business Overview
    Table 57. Abbott Diagnostics Carcinoembryonic Antigen (CEA) Product
    Table 58. Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2018-2023) & (US$ Million)
    Table 59. Abbott Diagnostics Recent Development
    Table 60. Quest Diagnostics Company Detail
    Table 61. Quest Diagnostics Business Overview
    Table 62. Quest Diagnostics Carcinoembryonic Antigen (CEA) Product
    Table 63. Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2018-2023) & (US$ Million)
    Table 64. Quest Diagnostics Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Carcinoembryonic Antigen (CEA) Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Carcinoembryonic Antigen (CEA) Market Share by Type: 2022 VS 2029
    Figure 3. CD66a Features
    Figure 4. CD66b Features
    Figure 5. CD66c Features
    Figure 6. CD66d Features
    Figure 7. CD66e Features
    Figure 8. CD66f Features
    Figure 9. Global Carcinoembryonic Antigen (CEA) Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2022 VS 2029
    Figure 11. Colorectal Cancer Case Studies
    Figure 12. Pancreatic Cancer Case Studies
    Figure 13. Ovarian Cancer Case Studies
    Figure 14. Breast Cancer Case Studies
    Figure 15. Thyroid Cancer Case Studies
    Figure 16. Others Case Studies
    Figure 17. Carcinoembryonic Antigen (CEA) Report Years Considered
    Figure 18. Global Carcinoembryonic Antigen (CEA) Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 19. Global Carcinoembryonic Antigen (CEA) Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 20. Global Carcinoembryonic Antigen (CEA) Market Share by Region: 2022 VS 2029
    Figure 21. Global Carcinoembryonic Antigen (CEA) Market Share by Players in 2022
    Figure 22. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2022)
    Figure 23. The Top 10 and 5 Players Market Share by Carcinoembryonic Antigen (CEA) Revenue in 2022
    Figure 24. North America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. North America Carcinoembryonic Antigen (CEA) Market Share by Country (2018-2029)
    Figure 26. United States Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Canada Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Europe Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Europe Carcinoembryonic Antigen (CEA) Market Share by Country (2018-2029)
    Figure 30. Germany Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. France Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. U.K. Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Italy Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Russia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Nordic Countries Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Share by Region (2018-2029)
    Figure 38. China Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Japan Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. South Korea Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. India Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Australia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Latin America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Latin America Carcinoembryonic Antigen (CEA) Market Share by Country (2018-2029)
    Figure 46. Mexico Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Brazil Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Share by Country (2018-2029)
    Figure 50. Turkey Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Saudi Arabia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Roche Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2018-2023)
    Figure 53. Abbott Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2018-2023)
    Figure 54. Quest Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2018-2023)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
Frequently Asked Questions
Carcinoembryonic Antigen (CEA) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Carcinoembryonic Antigen (CEA) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Carcinoembryonic Antigen (CEA) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports